21,725 Shares in Tilray Inc (NASDAQ:TLRY) Purchased by Dudley Capital Management LLC

Dudley Capital Management LLC acquired a new stake in shares of Tilray Inc (NASDAQ:TLRY) during the fourth quarter, HoldingsChannel reports. The firm acquired 21,725 shares of the company’s stock, valued at approximately $29,000.

A number of other large investors have also modified their holdings of the company. Connor Clark & Lunn Investment Management Ltd. grew its holdings in shares of Tilray by 2.6% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,487,500 shares of the company’s stock worth $2,617,000 after purchasing an additional 37,300 shares during the last quarter. Estate Counselors LLC raised its stake in shares of Tilray by 40.0% in the third quarter. Estate Counselors LLC now owns 70,000 shares of the company’s stock worth $123,000 after acquiring an additional 20,000 shares during the last quarter. Bank of Montreal Can lifted its position in shares of Tilray by 0.3% during the third quarter. Bank of Montreal Can now owns 2,176,506 shares of the company’s stock worth $3,787,000 after purchasing an additional 7,406 shares in the last quarter. The Manufacturers Life Insurance Company grew its stake in shares of Tilray by 4.9% during the third quarter. The Manufacturers Life Insurance Company now owns 715,672 shares of the company’s stock valued at $1,260,000 after purchasing an additional 33,194 shares during the last quarter. Finally, BNP Paribas Financial Markets increased its holdings in shares of Tilray by 1,314.1% in the third quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company’s stock valued at $3,202,000 after purchasing an additional 1,690,827 shares in the last quarter. 9.35% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group boosted their target price on Tilray from $2.00 to $3.00 and gave the stock a “buy” rating in a research report on Monday, January 13th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $2.70.

Tilray Price Performance

Shares of TLRY opened at $0.68 on Tuesday. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10. The stock has a market cap of $639.76 million, a P/E ratio of -2.27 and a beta of 2.13. The stock’s 50-day moving average price is $0.90 and its two-hundred day moving average price is $1.29. Tilray Inc has a 1 year low of $0.58 and a 1 year high of $2.97.

Tilray (NASDAQ:TLRY) last released its quarterly earnings data on Friday, January 10th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.07). The firm had revenue of $210.90 million during the quarter, compared to the consensus estimate of $216.34 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. On average, equities analysts predict that Tilray Inc will post -0.2 earnings per share for the current year.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.